Surgery As It’s Meant To Be Seen



ClearCam is dedicated to providing clinicians with innovative tools and technologies that maximize their vision and skill in the Operating Room.  We accomplish this through our core values of intellectual honesty, speed of light execution, direct communication, and simple, elegant design. We treat customers, employees, patients, and partners with respect, dignity, and professionalism.

It is our mission to create products that improve today and tomorrow’s surgical visualization platforms; platforms that employ cutting edge technology and open doors to new and exciting surgical procedures that provide better patient outcomes.



After our successful Seed Series Round in late 2018 we have been hard at work building the best products we can and get to FDA Clearance. We expect to be in Human Pilot Studies in late 2019.

May 2019

We have been hard at work in our lab in the Health Discovery Building at Dell Medical School at the University of Texas at Austin getting to a frozen design.

Testing + Regulatory
June 2019

Biocompatibility, mechanical, aging, sterilization, durability, and efficacy are in progress and on schedule.

FDA Clearance
October 2019

We anticipate FDA Clearance happening in October of 2019.

Pilot Trials
December 2019

We are currently working with hospital groups on Pilot Trials for the end of 2019 and early 2020. We plan to be in-market by Spring of 2020.


“You wouldn’t drive a car in a storm without windshield wipers”

Chris Idelson  |  Co-Founder



In 2016 Dr. John Uecker, a General Surgeon at Dell Seton Medical Center at the University of Texas, approached Dr. Chris Rylander, a professor at the University of Texas at Austin Cockrell School of Engineering, with a problem that he felt had no effective solution. Dr. Uecker performed about 350 laparoscopic surgeries a year and was incredibly frustrated by having to constantly clean the laparoscopic camera.  During the course of a laparoscopic procedure he would have to repeatedly break concentration, remove the camera from the patient's body, clean the camera, and then re-insert the scope into the patient and find his position to resume the surgery.  Dr. Uecker believed that longer surgeries, greater patient risk, higher cost, and surgical frustration had to have a solution.

When Dr. Rylander understood the problem he also felt it was worth solving and, with the help of PhD candidate Chris Idelson, set his lab into motion.  The goal was to create a simple, compatible in-vivo cleaner that would effectively deal with the main culprits of camera visual blockage- blood, tissue, fat, and condensation.  After over a year of development Dr. Rylander and Mr. Idelson had their initial product and Dr. Uecker began testing it. In the fall of 2017 the IP was patented and Doug Stoakley, an Entrepreneurial Advisor with the Innovation Center at the UT School of Engineering and longtime technology executive, joined ClearCam to drive operations, fundraising, and business strategy.  

It is 2019 and we are expecting to initiate Pilot Trials in the next 12 months.

Take a look at our Press Page for the latest news on what we are up to.


Want to Connect?

Pilot Trials

Contact Us